Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination
- PMID: 34688353
- PMCID: PMC8530465
- DOI: 10.1016/S0140-6736(21)02282-0
Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination
Conflict of interest statement
Oxford University has entered into a partnership with AstraZeneca for further development of ChAdOx1 nCoV-19 (AZD1222). AJP is chair of the UK Department of Health and Social Care's Joint Committee on Vaccination and Immunisation but does not participate in its discussions on COVID-19 vaccines, is a member of the WHO Strategic Advisory Group of Experts on Immunization, and a UK National Institute for Health Research senior investigator. All other authors declare no competing interests. The members of the Oxford COVID Vaccine Trial Group are listed in the appendix (pp 5–19).
References
-
- WHO Coronavirus disease (COVID-19): vaccines safety. Feb 19, 2021. https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
